Педиатрическая фармакология (Jan 2018)

The Role of Topical Glucocorticosteroid Methylprednisolone Aceponate in External Therapy of Atopic Dermatitis in Children

  • Yuliya G. Levina,
  • Anna A. Alekseeva,
  • Elena A. Vishneva,
  • Kamilla E. Efendieva,
  • Elena A. Dobrynina

DOI
https://doi.org/10.15690/pf.v14i6.1836
Journal volume & issue
Vol. 14, no. 6
pp. 520 – 526

Abstract

Read online

The article describes the main characteristics of local glucocorticosteroids (GCS) which are the «gold standard» for external therapy of atopic dermatitis allowing to achieve control over the disease quickly and effectively. Methylprednisolone aceponate 0.1% — non-fluorinated local GCS, the drug with the most favourable therapeutic index, the efficacy and safety of which has been demonstrated in numerous randomized trials — is the optimal therapeutic option in the treatment of AtD in children from 4 months.

Keywords